Literature DB >> 29903513

Prevalence and characteristics associated with high dose opioid users among older adults.

Shirley Musich1, Shaohung S Wang2, Luke Slindee3, Sandra Kraemer4, Charlotte S Yeh5.   

Abstract

Our primary objective was to determine the prevalence and characteristics of high dose opioid users among older adults. Study populations included adults ≥65 years with: 1) 12-month continuous medical plan enrollment; and 2) at least 2 opioid prescriptions with a cumulative day supply ≥15 days. Opioid users were categorized as high dose >120 milligram morphine equivalents (MME) per day or lower dose ≤120 MMEs per day. Among eligible insureds, 3% (N = 7616) were identified as high dose opioid users. Compared to lower dose users, high dose opioid users were male, younger, depressed, in poorer health, had back pain, used benzodiazepines and/or sleep medications, and used 4 or more pharmacies. The prevalence of high dose opioid users was relatively small but users were characterized by a complex mix of physical and mental health issues. Interventions to reduce reliance on opioids may need mental health management to promote more effective pain management.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  High dose opioids; Older adults; Pain management

Mesh:

Substances:

Year:  2018        PMID: 29903513     DOI: 10.1016/j.gerinurse.2018.06.001

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.361


  8 in total

1.  The Association Between the Supply of Nonpharmacologic Providers, Use of Nonpharmacologic Pain Treatments, and High-risk Opioid Prescription Patterns Among Medicare Beneficiaries With Persistent Musculoskeletal Pain.

Authors:  Ruchir N Karmali; Asheley C Skinner; Justin G Trogdon; Morris Weinberger; Steven Z George; Kristen Hassmiller Lich
Journal:  Med Care       Date:  2020-05       Impact factor: 2.983

2.  Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults.

Authors:  Cheng Chen; Wei-Hsuan Lo-Ciganic; Almut G Winterstein; Patrick Tighe; Yu-Jung J Wei
Journal:  Am J Prev Med       Date:  2021-11-19       Impact factor: 6.604

3.  Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.

Authors:  Sudha R Raman; Christopher Bush; Ruchir N Karmali; Lawrence H Greenblatt; Andrew W Roberts; Asheley C Skinner
Journal:  J Manag Care Spec Pharm       Date:  2019-09

4.  Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005-2013.

Authors:  Jessica M Brooks; Curtis Petersen; Stephanie M Kelly; Manney C Reid
Journal:  Int J Geriatr Psychiatry       Date:  2019-06-11       Impact factor: 3.850

5.  High-risk opioid prescribing trends in the outpatient setting prior to issuance of federal guidance.

Authors:  Alyssa M Peckham; Kathleen A Fairman; Gina Awanis; Nicole K Early
Journal:  Prev Med Rep       Date:  2019-05-17

6.  Regional and temporal variation in receipt of long-term opioid therapy among older breast, colorectal, lung, and prostate cancer survivors in the United States.

Authors:  Derrick C Gibson; Mukaila A Raji; Jacques G Baillargeon; Yong-Fang Kuo
Journal:  Cancer Med       Date:  2021-01-09       Impact factor: 4.452

7.  Do Formulation and Dose of Long-Term Opioid Therapy Contribute to Risk of Adverse Events among Older Adults?

Authors:  Monika Salkar; Sujith Ramachandran; John P Bentley; Ike Eriator; Gerald McGwin; Channing C Twyner; Yi Yang
Journal:  J Gen Intern Med       Date:  2021-07-13       Impact factor: 5.128

8.  Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Tham Thi Le; Siyeon Park; Michelle Choi; Marniker Wijesinha; Bilal Khokhar; Linda Simoni-Wastila
Journal:  BMJ Open Respir Res       Date:  2020-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.